Jacques LeLorier

4.5k total citations
95 papers, 3.3k citations indexed

About

Jacques LeLorier is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pharmacology. According to data from OpenAlex, Jacques LeLorier has authored 95 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Surgery, 25 papers in Cardiology and Cardiovascular Medicine and 15 papers in Pharmacology. Recurrent topics in Jacques LeLorier's work include Health Systems, Economic Evaluations, Quality of Life (14 papers), Inflammatory mediators and NSAID effects (12 papers) and Lipoproteins and Cardiovascular Health (10 papers). Jacques LeLorier is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (14 papers), Inflammatory mediators and NSAID effects (12 papers) and Lipoproteins and Cardiovascular Health (10 papers). Jacques LeLorier collaborates with scholars based in Canada, United States and United Kingdom. Jacques LeLorier's co-authors include Elham Rahme, Lucie Blais, Odile Sheehy, Alain Desgagné, Louise Pilote, Lise M. Bjerre, Amir Abbas Tahami Monfared, Madéleine Durand, Jean-Guy Baril and Cécile Tremblay and has published in prestigious journals such as Annals of Internal Medicine, Gastroenterology and Journal of the American College of Cardiology.

In The Last Decade

Jacques LeLorier

93 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacques LeLorier Canada 30 915 864 529 479 391 95 3.3k
Maria Carla Roncaglioni Italy 25 798 0.9× 1.5k 1.7× 720 1.4× 262 0.5× 364 0.9× 101 3.8k
Walter Smalley United States 37 1.4k 1.5× 733 0.8× 1.2k 2.3× 370 0.8× 408 1.0× 68 5.0k
Patricia R. Hebert United States 23 900 1.0× 1.4k 1.6× 232 0.4× 294 0.6× 379 1.0× 49 3.0k
Torben Haghfelt Denmark 28 1.9k 2.1× 2.2k 2.5× 232 0.4× 261 0.5× 320 0.8× 115 4.4k
Loes E. Visser Netherlands 36 723 0.8× 690 0.8× 479 0.9× 276 0.6× 430 1.1× 124 4.3k
Linda E. Lévesque Canada 24 459 0.5× 482 0.6× 423 0.8× 97 0.2× 489 1.3× 50 3.1k
A Notarbartoló Italy 34 2.2k 2.4× 999 1.2× 290 0.5× 325 0.7× 342 0.9× 152 4.3k
John Goudevenos Greece 38 1.6k 1.8× 3.1k 3.6× 283 0.5× 218 0.5× 590 1.5× 194 6.3k
Raymond G. Schlienger Switzerland 34 565 0.6× 759 0.9× 548 1.0× 62 0.1× 225 0.6× 81 4.0k
Susana Perez‐Gutthann United States 30 848 0.9× 864 1.0× 1.4k 2.7× 74 0.2× 378 1.0× 80 5.1k

Countries citing papers authored by Jacques LeLorier

Since Specialization
Citations

This map shows the geographic impact of Jacques LeLorier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques LeLorier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques LeLorier more than expected).

Fields of papers citing papers by Jacques LeLorier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacques LeLorier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques LeLorier. The network helps show where Jacques LeLorier may publish in the future.

Co-authorship network of co-authors of Jacques LeLorier

This figure shows the co-authorship network connecting the top 25 collaborators of Jacques LeLorier. A scholar is included among the top collaborators of Jacques LeLorier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacques LeLorier. Jacques LeLorier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tardif, Jean‐Claude, Denis Roy, Léna Rivard, et al.. (2023). A Cost-Effectiveness Analysis of Biomarkers for Risk Prediction in Atrial Fibrillation. Molecular Diagnosis & Therapy. 27(3). 383–394. 1 indexed citations
2.
Brophy, James M., et al.. (2021). Domperidone increases harmful cardiac events in Parkinson's disease: A Bayesian re-analysis of an observational study. Journal of Clinical Epidemiology. 140. 93–100. 3 indexed citations
3.
LeLorier, Jacques, et al.. (2017). Cost-Effectiveness Analysis of Fosfomycin for Treatment of Uncomplicated Urinary Tract Infections in Ontario. Canadian Journal of Infectious Diseases and Medical Microbiology. 2017. 1–11. 9 indexed citations
4.
Guertin, Jason R., Elham Rahme, Colin R. Dormuth, & Jacques LeLorier. (2016). Head to head comparison of the propensity score and the high-dimensional propensity score matching methods. BMC Medical Research Methodology. 16(1). 22–22. 35 indexed citations
5.
Guertin, Jason R., Elham Rahme, & Jacques LeLorier. (2016). Performance of the high-dimensional propensity score in adjusting for unmeasured confounders. European Journal of Clinical Pharmacology. 72(12). 1497–1505. 39 indexed citations
6.
Guertin, Jason R., Aihua Liu, Michał Abrahamowicz, et al.. (2011). Analysis of Willingness to Pay for Implantable Cardioverter–Defibrillator Therapy. The American Journal of Cardiology. 107(3). 423–427. 7 indexed citations
7.
Guertin, Jason R., et al.. (2011). Savings from the use of a probiotic formula in the prophylaxis of antibiotic-associated diarrhea. Journal of Medical Economics. 15(1). 53–60. 22 indexed citations
8.
Guertin, Jason R., Marc Dorais, Paul Khairy, et al.. (2011). Atrial Fibrillation: A Real-Life Observational Study in the Québec Population. Canadian Journal of Cardiology. 27(6). 794–799. 5 indexed citations
9.
Durand, Madéleine, Odile Sheehy, Jean-Guy Baril, Jacques LeLorier, & Cécile Tremblay. (2011). Association Between HIV Infection, Antiretroviral Therapy, and Risk of Acute Myocardial Infarction: A Cohort and Nested Case–Control Study Using Québec's Public Health Insurance Database. JAIDS Journal of Acquired Immune Deficiency Syndromes. 57(3). 245–253. 205 indexed citations
10.
Kruschinski, Carsten, Odile Sheehy, Eva Hummers, & Jacques LeLorier. (2010). Fracture risk of patients suffering from dizziness: A retrospective cohort study. European Journal of General Practice. 16(4). 229–235. 5 indexed citations
11.
Sheehy, Odile, Jacques LeLorier, & Stéphane Rinfret. (2008). Restrictive access to clopidogrel and mortality following coronary stent implantation. Canadian Medical Association Journal. 178(4). 413–420. 22 indexed citations
12.
Chabot, Isabelle, Jacques LeLorier, & Martin E. Blackstein. (2008). The challenge of conducting pharmacoeconomic evaluations in oncology using crossover trials: The example of sunitinib for gastrointestinal stromal tumour. European Journal of Cancer. 44(7). 972–977. 27 indexed citations
13.
Sheehy, Odile, et al.. (2008). Osteoporosis among patients with type 1 and type 2 diabetes. Diabetes & Metabolism. 34(3). 193–205. 112 indexed citations
14.
Rahme, Elham, Youssef Toubouti, & Jacques LeLorier. (2006). Utilization and cost comparison of current and optimal prescribing of nonsteroidal antiinflammatory drugs in Quebec, Canada.. PubMed. 33(3). 588–96. 6 indexed citations
15.
LeLorier, Jacques. (2006). The value of lowering blood pressure. Canadian Journal of Cardiology. 22(1). 63–64. 1 indexed citations
16.
Pilon, Danielle, et al.. (2003). Oral anticoagulants and the risk of osteoporotic fractures among elderly. Pharmacoepidemiology and Drug Safety. 13(5). 289–294. 36 indexed citations
17.
RN, et al.. (1999). Pharmacoeconomics and Health Policy. PharmacoEconomics. 16(5). 425–432. 26 indexed citations
18.
Garbe, Edeltraut, Jacques LeLorier, J-F Boivin, & Samy Suissa. (1997). Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma.. American Journal of Ophthalmology. 124(1). 136–137. 5 indexed citations
19.
Latour, Y., et al.. (1977). Effects of sotalol in twenty patients with cardiac arrhythmias.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 15(6). 275–8. 11 indexed citations
20.
Hong, Enrique, et al.. (1967). AUTOINHIBITION IN RABBIT AORTIC STRIPS AFTER EPINEPHRINE. Journal of Pharmacology and Experimental Therapeutics. 157(2). 303–310. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Carla Roncaglioni Breakdown of academic impact, for papers by Walter Smalley Breakdown of academic impact, for papers by Patricia R. Hebert Breakdown of academic impact, for papers by Torben Haghfelt Breakdown of academic impact, for papers by Loes E. Visser Breakdown of academic impact, for papers by Linda E. Lévesque Breakdown of academic impact, for papers by A Notarbartoló Breakdown of academic impact, for papers by John Goudevenos Breakdown of academic impact, for papers by Raymond G. Schlienger Breakdown of academic impact, for papers by Susana Perez‐Gutthann
Rankless by CCL
2026